A phase II multi-institutional study to evaluate gemcitabine and fractionated stereotactic body radiotherapy for unresectable, locally advanced pancreatic adenocarcinoma Meeting Abstract
| Authors: | Herman, J. M.; Chang, D. T.; Goodman, K. A.; Wild, A. T.; Laheru, D.; Zheng, L.; Diaz, L. A.; Le, D. T.; Raman, S. P.; Leal, J. P.; Chaudhry, M. A.; Sugar, E.; Columbo, L. A.; Tom, A.; Limaye, M. R.; Edil, B. H.; Oteiza, K.; Hacker-Prietz, A.; Wolfgang, C. L.; Koong, A. |
| Abstract Title: | A phase II multi-institutional study to evaluate gemcitabine and fractionated stereotactic body radiotherapy for unresectable, locally advanced pancreatic adenocarcinoma |
| Meeting Title: | 48th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 30 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2012 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2012-05-20 |
| Language: | English |
| ACCESSION: | WOS:000318009805038 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2012.30.15_suppl.4045 |
| Notes: | Meeting Abstract: 4045 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
